mazdaki

CERUS Will Break out of the wedge

Long
NASDAQ:CERS   Cerus Corporation
0
FDA approval.
Start of US customer base
Double bottom on a daily base.
Cup and Handle formation.
Wedge formation but not pierced yet.
First Target raised to $8 ish
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.